Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.068 EUR | +1.71% | +1.14% | -17.08% |
14/03 | Abionyx Pharma: to benefit from a 1ME grant from Bpifrance | CF |
11/03 | Abionyx: reduced net loss in 2023 | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.08% | 36.12M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+4.13% | 22.25B | |
-14.77% | 21.68B | |
-8.56% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- ABNX Stock
- News ABIONYX Pharma
- Abionyx Pharma Names IRIS Pharma Founder as Chief Scientific Officer Amid Purchase Agreement